KT Medical Service Public Company LimitedSET: KTMS🇹🇭 TH

Internal Control · 2024

Internal Control — Board Opinion

Introduction

The Board of Directors recognizes the importance of having a good internal control system to ensure that the Group has an appropriate and sufficient internal control system in accordance with the principles of good corporate governance in overseeing business operations. It also aims to prevent risks and damages that may occur to the Group and stakeholders, as well as to ensure the preparation and disclosure of complete, accurate, and reliable financial reports.


In addition, the Board of Directors has established and reviewed the corporate risk management framework by assessing and analyzing both internal and external risk factors affecting the organization. This is to be implemented throughout the organization and used to systematically control the organization's risks. The Board has assigned the risk management working group to oversee the implementation of risk management policies and frameworks within the organization, monitor the risk management process, the adequacy of key risk management, and support and develop risk management at all levels throughout the organization.

Summary of the Board's Opinion on Internal Control

At the Annual General Meeting of Shareholders 2567, which was attended by all 3 audit committee members, the Board of Directors assessed the adequacy of the Company's and its subsidiaries' internal control systems. By inquiring information from the management, it was concluded that from the assessment of the internal control system following the guidelines of The Committee of Sponsoring Organizations of Treadway Commission (“COSO”) using the internal control adequacy assessment form of the Securities and Exchange Commission (SEC), which consists of 5 components as follows:

1) Control Environment

2) Risk Assessment

3) Control Activities

4) Information & Communication

5) Monitoring Activities


The Board of Directors is of the opinion that the Company has established management and internal control systems in 5 areas according to the COSO framework. Overall, it is in good standing, adequate and appropriate for the size of the business and the current situation. The management supports employees in the organization to realize the importance of internal control. It also allocates sufficient and appropriate personnel to ensure that the Company's operations are carried out in accordance with the objectives, relevant laws and regulations, and good corporate governance principles. The Company has clearly defined roles and responsibilities, as well as established appropriate written regulations, policies, and authorization of operations.


In addition, the Company has established an independent internal audit function to monitor and evaluate internal control by hiring an external internal audit firm (Outsource) to audit the internal control system. The report is directly submitted to the Audit Committee. The Audit Committee has considered and approved the Company's internal control adequacy assessment form for the year 2567. The report will be presented at the Audit Committee and Board of Directors meetings within the first quarter of 2568.

Adequacy & Appropriateness of the Internal Control System

Internal Control Framework Used

FrameworkDetail
The Committee of Sponsoring Organizations of the Treadway Commission (COSO)

Assess the internal control system following the guidelines of The Committee of Sponsoring Organizations of Treadway Commission (“COSO”) by using the assessment form for the adequacy of the internal control system of the Securities and Exchange Commission (SEC), which consists of 5 components as follows: 1) Control Environment

2) Risk Assessment

3) Control Activities

4) Information & Communication

5) Monitoring Activities

Internal Control Deficiencies

Number of Deficiencies

MetricCurrent YearPrevious YearTwo Years Ago
Total number of internal control system deficiencies (cases)000

Audit Committee & Auditor Observations

Audit Committee's Opinion Differs from the Board's

No

Auditor Has Observations on Internal Control

No

Opinion on the Head of Internal Audit

Head of Internal Audit

3160

Audit Committee's Opinion on the Head of Internal Audit

The Audit Committee Meeting No. 1/2024, held on February 26, 2024, resolved to appoint Proud Advisory Company Limited as the Company's internal auditor for the year 2024, with Mr. Prit Buabuapan as the Head of Internal Audit and the person in charge of the operation. (The qualifications of the Head of Internal Audit are shown in Appendix 3 "Details of the Head of Internal Audit")

Appointment, Discharge & Transfer of the Head of Internal Audit

Requires Audit Committee Approval

Yes

Description

The consideration and approval of the appointment, removal, and transfer of the Head of Internal Audit must be approved by the Audit Committee. The qualifications of the Head of Internal Audit are provided in Appendix 3.

Related Party Transactions

Has Related Party Transactions

Yes

Counterparties & Transactions

Monetary Unit

1

Counterparties with Potential Conflicts

NamePerson / Juristic PersonType of BusinessNature of RelationshipAs of Date (YYYY-MM-DD)
Filter Vision Public Company LimitedJuristic PersonBusinesses related to Water Treatment Systems and Hygienic Medical Services, particularly those associated with Dialysis Centers.

Holds 53.08 percent of the company's shares.

2024-12-31T00:00
Dr. Vijit TechasakasemPerson

Company director/ Authorized director of the company/ Shareholder of KT Medical Service Public Company Limited, Irving Corporation Limited, Medical Vision Limited, and Nephro Vision Limited, and spouse of Mrs. Kanchana Pongpattanadecha.

2024-12-31T00:00
Miss Supaphan YiamlengamkoonPerson

Is an executive of Filter Vision Public Company Limited.

2024-12-31T00:00
InnovaTech (Asia) Company LimitedJuristic PersonConsulting, designing, selling equipment Installation and maintenance of water and clean energy production system solutions in the field of ESG (Environmental, Social, Governance) for various government and private agencies that are interested in ESG or affected by environmental policies.

It is a subsidiary of Filter Vision Public Company Limited.

2024-12-31T00:00
Dr. Pisarn TechakesamPerson

Is the younger brother of Dr. Vijit Techekszem

2024-12-31T00:00
Miss Thanapha DetchakesemPerson

Is an executive of Filter Vision Public Company Limited and the younger sister of Dr. Vijit Techasakasem.

2024-12-31T00:00

Transactions by Counterparty

Transactions
99025.0 · Necessity: KT Medical Service Public Company Limited purchased four Water Logic water dispensers from Filter Vision Public Company Limited. The dispensers were for the following branches: Thanakhan, Nong Kung Si, Somdej Phra Yupparat Dan Sai, and Khemarat, with one dispenser per branch. The purchase price was determined after comparing quotes from other vendors following the company's procurement process. · Description: Asset Purchase · As of yesteryear: 19855840.0 · Nature of transaction: KTMS: Asset Purchase · Audit committee opinion: The list resulting from the consideration of the reasonableness of the price and the transactions by the Audit Committee and the Board of Directors. · 756839.69 · Necessity: KT Medical Service Public Company Limited charges Filter Vision Public Company Limited for document copying, SAP system usage, T-Reg program usage, and system maintenance. These service fees are based on actual usage. · Description: Service fee · As of yesteryear: 685254.08 · Nature of transaction: KTMS: Service Fees · Audit committee opinion: The list resulting from the consideration of the reasonableness of the price and the transactions by the Audit Committee and the Board of Directors. · 172994.16 · Necessity: In 2023, KT Medical Service Public Company Limited had a lease agreement for office and warehouse space with Filter Vision Public Company Limited. The monthly rent was 11,683.58 baht. In September 2023, additional space was leased, bringing the total monthly rent to 14,006.63 baht. These rental rates are in line with market prices. The Company is responsible for utilities, which are paid at a flat rate of 18,565.99 baht per month, based on the previous year's electricity and water consumption. In 2024, KT Medical Service Public Company Limited has a lease agreement for office and warehouse space with Filter Vision Public Company Limited. The monthly rent is 14,416.18 baht. These rental rates are in line with market prices. The Company is responsible for utilities, which are paid at a flat rate of 17,100.00 baht per month, based on the previous year's electricity and water consumption. · Description: Office and warehouse rental · As of yesteryear: 149495.16 · Nature of transaction: KTMS: Office and Warehouse Space for Rent · Audit committee opinion: The list resulting from the consideration of price reasonableness and the reports from the Audit Committee and the Board of Directors. · 205200.0 · Necessity: The public utility costs, which the company is responsible for, are a monthly lump sum payment of 17,100.00 baht, based on the previous year's electricity and water consumption rates. · Description: Public utility costs · As of yesteryear: 222791.88 · Nature of transaction: KTMS: Utility Expenses · Audit committee opinion: The list resulting from the consideration of the reasonableness of the price and the transactions by the Audit Committee and the Board of Directors. · 359300.51 · Necessity: KT Medical Service Public Company Limited leases office and warehouse space to Filter Vision Public Company Limited at a monthly rate of 14,416.18 Baht. This rental rate is in accordance with market prices. · Description: Leasehold Liabilities · As of yesteryear: 486247.11 · Nature of transaction: Leasehold liabilities · Audit committee opinion: The list resulting from the consideration of the reasonableness of the price and the transactions by the Audit Committee and the Board of Directors. · 127822.12 · Necessity: During the years 2566 and 2567, Erving Corporation Limited sold products to Filter Vision Public Company Limited (FVC) at prices below the standard price list. This pricing was due to the following reasons: 1) The sales to FVC were standard transactions without any after-sales warranty obligations. 2) The products sold were outdated water system equipment, sold at cost. The terms of trade were consistent with those offered to other customers. Erving Corporation Limited also provides water analysis services to Filter Vision Public Company Limited (FVC) as FVC does not have an in-house water analysis laboratory. These services are billed on a per-analysis basis. · Description: Product Sales · As of yesteryear: 287575.85 · Nature of transaction: IRV: Product Sales · Audit committee opinion: The list resulting from the consideration of the reasonableness of the price and the transactions by the Audit Committee and the Board of Directors. · 179900.0 · Necessity: Erving Corporation Limited provides water analysis services to Filter Vision Public Company Limited (FVC) due to FVC's lack of an in-house water analysis laboratory. The service fee is charged on a per-analysis basis. · Description: Revenue from water analysis services · As of yesteryear: 172300.0 · Nature of transaction: IRV: Revenue from Water Analysis Services · Audit committee opinion: The list resulting from the consideration of price reasonableness and due diligence by the Audit Committee and the Board of Directors. · 4505540.2 · Necessity: - In 2023 and 2024, Irving Corporation Co., Ltd. purchased goods from Filter Vision Public Company Limited. The purchase price of such goods was compared with other sellers following the company's procurement process. - In 2024, Irving Corporation Co., Ltd. purchased one asset from Filter Vision Public Company Limited, consisting of one Water Logic water dispenser. The purchase price of such assets was compared with other sellers following the company's procurement process. · Description: Purchase · As of yesteryear: 8687433.0 · Nature of transaction: IRV: Purchase · Audit committee opinion: The list resulting from the consideration of the reasonableness of the price and the transactions by the Audit Committee and the Board of Directors. · 35850.0 · Necessity: Erving Corporation Limited has purchased one asset from Filter Vision Public Company Limited, consisting of one Water Logic water dispenser. The purchase price of the asset was determined after comparing prices with other vendors in accordance with the company's procurement process. · Description: Asset Purchase · As of yesteryear: 0.0 · Nature of transaction: IRV: Asset Purchase · Audit committee opinion: The list resulting from the consideration of the reasonableness of the price and the transactions by the Audit Committee and the Board of Directors. · 506794.93 · Necessity: During the years 2566 and 2567, Erving Corporation Limited received revenue from Filter Vision Public Company Limited for document copying fees, SAP system usage fees, T-Reg program usage fees, and system maintenance fees. The service fees were charged based on actual usage. · Description: Service charge · As of yesteryear: 591294.5 · Nature of transaction: IRV : Service Charge · Audit committee opinion: The list resulting from the consideration of the reasonableness of the price and the transactions by the Audit Committee and the Board of Directors. · 213201.36 · Necessity: In 2023, Irving Corporation Limited entered into an agreement with Filter Vision Public Company Limited for the lease of office space and warehouses. The monthly rental fee is 17,766.78 Baht, which is in line with market rates. The company is responsible for utilities, which are charged at a flat rate of 25,859.78 Baht per month based on the previous year's electricity and water consumption. In 2023, Irving Corporation Limited also leased warehouse space in Lamphun province from Filter Vision Public Company Limited. The monthly rental fee was 1,330.00 Baht. The company was responsible for utilities, with electricity and water charges billed based on actual usage. The rental rate was in accordance with market prices. Irving Corporation Limited leased the warehouse space for a period of six months, terminating the lease in July 2023. In 2024, Irving Corporation Limited has an agreement with Filter Vision Public Company Limited for the lease of office space and warehouses. The monthly rental fee is 17,766.78 Baht, consistent with market rates. The company is responsible for utilities, which are charged at a flat rate of 20,031.00 Baht per month based on the previous year's electricity and water consumption. · Description: Office and warehouse rental · As of yesteryear: 221181.36 · Nature of transaction: IRV: Office and Warehouse Rental · Audit committee opinion: The list resulting from the consideration of the reasonableness of the price and the transactions by the Audit Committee and the Board of Directors. · 240372.0 · Necessity: The public utility costs under the Company's responsibility are paid monthly at 20,031.00 Baht. · Description: Public utility costs · As of yesteryear: 310444.03 · Nature of transaction: IRV: Public Utility Value · Audit committee opinion: The list resulting from the consideration of the reasonableness of the price and the transactions by the Audit Committee and the Board of Directors. · 1319550.0 · Necessity: In 2023 and 2024, Medical Vision Co., Ltd. has a list of service fees from Filter Vision Public Company Limited. These service fees are calculated based on the working hours that Filter Vision Public Company Limited's employees have worked for Medical Vision Co., Ltd. · Description: Cat price · As of yesteryear: 1083280.0 · Nature of transaction: MV: Lump Sum Price · Audit committee opinion: The list, which may be adjusted upon the Audit Committee and the Board of Directors' review of the price's reasonableness and the transaction's details. · 217132.17 · Necessity: For the years 2566 and 2567, Medical Vision Co., Ltd. incurred expenses related to document copying, SAP system usage fees, T-Reg program usage fees, and system maintenance fees. These expenses were invoiced by Filter Vision Public Company Limited, and the service fees were based on actual usage. · Description: Service Charge · As of yesteryear: 219238.22 · Nature of transaction: MV: Service Fee · Audit committee opinion: The list resulting from the consideration of the reasonableness of the price and the transactions by the Audit Committee and the Board of Directors. · 55441.68 · Necessity: In 2023, Medical Vision Co., Ltd. entered into a lease agreement for office and warehouse space with Filter Vision Public Company Limited, with a monthly rent of 4,620.14 baht. The rental rate is in line with market prices. The Company is responsible for utilities, which are paid at a flat rate of 1,989.20 baht per month, based on the previous year's electricity and water consumption. In 2024, Medical Vision Co., Ltd. has a lease agreement for office and warehouse space with Filter Vision Public Company Limited, with a monthly rent of 4,620.14 baht. The rental rate is in line with market prices. The Company is responsible for utilities, which are paid at a flat rate of 1,465.00 baht per month, based on the previous year's electricity and water consumption. · Description: Office and warehouse rental · As of yesteryear: 55441.68 · Nature of transaction: MV: Office and Warehouse Space for Rent · Audit committee opinion: The list resulting from the consideration of price reasonableness and the reports from the Audit Committee and the Board of Directors. · 17580.0 · Necessity: In 2023, Medical Vision Co., Ltd. leased office and warehouse space from Filter Vision Public Company Limited at a monthly rent of 4,620.14 Baht. This rental rate is in line with market prices. The Company is responsible for utilities, which are paid at a flat rate of 1,989.20 Baht per month, based on the previous year's electricity and water consumption. In 2024, Medical Vision Co., Ltd. leased office and warehouse space from Filter Vision Public Company Limited at a monthly rent of 4,620.14 Baht. This rental rate is in line with market prices. The Company is responsible for utilities, which are paid at a flat rate of 1,465.00 Baht per month, based on the previous year's electricity and water consumption. · Description: Public utility costs · As of yesteryear: 23870.4 · Nature of transaction: MV: Utility Costs · Audit committee opinion: The list resulting from the consideration of the reasonableness of the price and the transactions by the Audit Committee and the Board of Directors. · 35850.0 · Necessity: Nephro Vision Public Company Limited has purchased assets from Filter Vision Public Company Limited. - In 2023, there were two purchases of Water Logic water dispensers, one each for the Prachuap Khiri Khan and Phitsanulok clinics. The purchase price of these assets was compared to other sellers following the procurement process. - In 2024, there was one purchase of a Water Logic water dispenser for the Pa Sang branch. The purchase price of this asset was compared to other sellers following the procurement process. · Description: Asset Purchase · As of yesteryear: 69350.0 · Nature of transaction: NEP: Asset Acquisition · Audit committee opinion: The list resulting from the consideration of price reasonableness and the reports from the Audit Committee and the Board of Directors. · 106311.71 · Necessity: In 2023 and 2024, Nevro Vision Co., Ltd. has a list of service fees for using the T-Reg program, which are charged to Filter Vision Public Company Limited. These service fees are based on actual usage. · Description: Service Charge · As of yesteryear: 21004.5 · Nature of transaction: NEP: Service Charge · Audit committee opinion: The list resulting from the consideration of the reasonableness of the price and the transactions by the Audit Committee and the Board of Directors.
0.0 · Necessity: In 2023, Dr. Vijit Techakesin, Dr. Pisarn Techakesin, and Ms. Thanapha Techakesin jointly pledged their land as collateral for a total credit line of 62.73 million baht to KT Medical Service Public Company Limited, as follows: - O/D: 10.00 million baht - LG: 12.50 million baht - T/L Dialysis Machine: 9.03 million baht - T/L Dialysis Machine: 13.86 million baht - T/L Dialysis Center, Tak Province: 7.33 million baht - T/L Dialysis Machine: 10.00 million baht No compensation was received for the aforementioned guarantees, in accordance with the conditions set by the financial institution. In 2024, following the 2023 joint land collateralization by Dr. Vijit Techakesin, Dr. Pisarn Techakesin, and Ms. Thanapha Techakesin for a total credit line of 62.73 million baht to KT Medical Service Public Company Limited, an amendment to the loan agreement was recorded in February 2024. The amendment transferred ownership solely to Dr. Vijit Techakesin. Additionally, in April 2024, the land title deed was updated to reflect Dr. Vijit Techakesin as the sole owner, and he continued to guarantee the total credit line of 62.73 million baht to KT Medical Service Public Company Limited. · Description: Loan Guarantee to the Company by Financial Institutions · As of yesteryear: 33398200.0 · Nature of transaction: KTMS: Loan Guarantee for the Company with Financial Institutions · Audit committee opinion: The list resulting from the consideration of the reasonableness of the price and the transactions by the Audit Committee and the Board of Directors. · 0.0 · Necessity: In 2023, Dr. Vijit Techasakul provided guarantees for loans totaling THB 12.00 million to KT Medical Service Public Company Limited as follows: O/D THB 3.00 million T/L THB 9.00 million These guarantees were provided without any remuneration, in accordance with the conditions set by the creditor financial institutions. The company has negotiated with the financial institutions to release the guarantees, and they have agreed to do so after the company is listed on the Stock Exchange of Thailand. · Description: Loan Guarantee to the Company by Financial Institutions · As of yesteryear: 4657000.0 · Nature of transaction: IRV: Loan Guarantee to the Company by Financial Institutions · Audit committee opinion: The list resulting from the consideration of the reasonableness of the price and the transactions by the Audit Committee and the Board of Directors. · 0.0 · Necessity: In 2023, Dr. Vijit Techakesame, Dr. Pisarn Techakesame, and Ms. Thanapha Techakesame jointly pledged their land as collateral for a total credit line of 5.00 million baht to Medical Vision Company Limited, as follows: - LG: 3.00 million baht - FW: 2.00 million baht No compensation was received for the aforementioned guarantees, in accordance with the conditions set by the creditor financial institution. In 2024, following the 2023 pledge of land jointly owned by Dr. Vijit Techakesame, Dr. Pisarn Techakesame, and Ms. Thanapha Techakesame as collateral for a total credit line of 5.00 million baht to Medical Vision Company Limited: - In February 2024, an amendment to the loan agreement was recorded, transferring ownership to Dr. Vijit Techakesame as the sole owner. - In April 2024, the name of the land title deed holder was changed to Dr. Vijit Techakesame as the sole owner, and a credit line of 5.00 million baht was guaranteed to Medical Vision Company Limited. - In November 2024, an amendment to the loan agreement was recorded, releasing Dr. Vijit Techakesame's land title deed and replacing it with the land title deed of KT Medical Service Public Company Limited as collateral for the total credit line of 5.00 million baht. · Description: Loan Guarantee to the Company by Financial Institutions · As of yesteryear: 1490500.0 · Nature of transaction: MV: Loan Guarantee for the Company with Financial Institutions · Audit committee opinion: The list resulting from the consideration of the reasonableness of the price and the transactions by the Audit Committee and the Board of Directors.
0.0 · Necessity: Ms. Supaphan Yiamsaengamkul used to provide her land title deed as a guarantee for a loan worth 62.73 million baht to KT Medical Service Public Company Limited. In November 2024, an amendment to the loan agreement was recorded, withdrawing Ms. Supaphan Yiamsaengamkul's land title deed from the agreement. The loan, still valued at 62.73 million baht, is now secured by a land title deed owned by KT Medical Service Public Company Limited. · Description: Loan Guarantee to the Company by Financial Institutions · As of yesteryear: 33398200.0 · Nature of transaction: KTMS: Loan Guarantee for the Company with Financial Institutions · Audit committee opinion: The list resulting from the consideration of the reasonableness of the price and the transactions by the Audit Committee and the Board of Directors. · 0.0 · Necessity: - In 2023, Ms. Supaphan Yiamlaemkamol used her land title deed as collateral to secure a total credit line of 9.50 million baht for Irving Corporation Co., Ltd. as follows: O/D 5.00 million baht LG 4.50 million baht No compensation was received for the aforementioned guarantees, in accordance with the conditions set by the creditor financial institution. - In 2024, Ms. Supaphan Yiamlaemkamol used her land title deed as collateral to secure a total credit line of 9.50 million baht for Irving Corporation Co., Ltd. In November 2024, an amendment to the loan agreement was recorded, withdrawing Ms. Supaphan Yiamlaemkamol's land title deed as collateral and replacing it with the land title deed of KT Medical Service Public Company Limited, securing a total credit line of 9.50 million baht. · Description: Loan Guarantee to the Company by Financial Institutions · As of yesteryear: 1841825.29 · Nature of transaction: IRV: Loan Guarantee to the Company by Financial Institutions · Audit committee opinion: The list resulting from the consideration of the reasonableness of the price and the transactions by the Audit Committee and the Board of Directors. · 0.0 · Necessity: Ms. Supaporn Yiamlaemkamkoon's land title deed was used as collateral for a loan totaling 5.00 million baht to Medical Vision Company Limited, with the following breakdown: - LG: 3.00 million baht - FW: 2.00 million baht No compensation was received for the aforementioned guarantees, as per the conditions set by the creditor financial institution. - In 2024, Ms. Supaporn Yiamlaemkamkoon used her land title deed as collateral for a loan totaling 5.00 million baht to Medical Vision Company Limited. In November 2024, an amendment to the loan agreement was recorded, whereby Ms. Supaporn Yiamlaemkamkoon's land title deed was released and replaced with the land title deed of KT Medical Service Public Company Limited as collateral for the loan totaling 5.00 million baht. · Description: Loan Guarantee to the Company by Financial Institutions · As of yesteryear: 1490500.0 · Nature of transaction: MV: Loan Guarantee for the Company with Financial Institutions · Audit committee opinion: The list, derived from the Audit Committee and the Board of Directors' deliberations on price reasonableness and transactions.
3554.13 · Necessity: In 2024, Erving Corporation Limited sold goods to Innovate (Asia) Limited at a regular selling price, not lower than the price list. · Description: Product Sales · As of yesteryear: 0.0 · Nature of transaction: IRV : Product Sales · Audit committee opinion: The list resulting from the consideration of price reasonableness and due diligence by the Audit Committee and the Board of Directors. · As of year before yesteryear: 0.0 · 57562.5 · Necessity: Erving Corporation Limited has purchased goods from Innovatech (Asia) Limited. The purchase price of such goods has been compared with other sellers in accordance with the company's procurement process. · Description: Purchase Products · As of yesteryear: 0.0 · Nature of transaction: Purchase · Audit committee opinion: The list resulting from the consideration of the reasonableness of the price and the transactions by the Audit Committee and the Board of Directors. · As of year before yesteryear: 0.0

Policy & Future Trends

Policy, Measures & Approval Process

Measures or procedures for approving related party transactions


In 1984, the Board of Directors reviewed the Company's policies and procedures for transactions with persons or juristic persons who may have a conflict of interest to ensure that the transactions are transparent and in the best interests of the Company. The summary is as follows:

Transactions between the Company and directors, executives, connected persons, related persons, or related persons of such persons ("persons who may have a conflict of interest") must be on an arm's length basis or be transactions that are commercial terms in the same manner that a reasonable person would conduct with a general counterparty in the same circumstances, with bargaining power free from the influence of being a director, executive, or connected person (as the case may be), under reasonable, verifiable conditions, and not resulting in a transfer of benefits. The criteria for entering into transactions are as follows:


Case 1: Related party transactions that are normal business transactions

The Board of Directors has approved in principle that the management can approve related party transactions that are commercial agreements with general commercial terms between the Company and its subsidiaries with directors, executives, major shareholders, or connected persons if such transactions are commercial agreements in the same manner that a reasonable person would conduct with a general counterparty in the same circumstances, with bargaining power free from the influence of being a director, executive, or connected person (as the case may be), and are commercial agreements approved by the Board of Directors or in accordance with the principles approved by the Board of Directors. The Company will prepare a report summarizing such transactions for reporting at the Audit Committee meetings and Board of Directors meetings every quarter.


Case 2: Other related party transactions

For other related party transactions that require approval by the Board of Directors' Meeting or the Shareholders' Meeting according to the criteria set by the Stock Exchange of Thailand, the Audit Committee shall consider and provide opinions on the necessity of entering into the transactions and the appropriateness of the transaction price. The Audit Committee shall consider whether the terms and conditions are in accordance with normal business practices in the market, which can be compared with the prices offered to external parties and are fair, reasonable, and verifiable. In the event that the Audit Committee does not have expertise in considering the related party transactions that may occur, the Company will have an independent expert, such as an auditor or an independent property valuer, provide an opinion on such related party transactions. The Company's related party transactions with persons who may have a conflict of interest must be considered by the Audit Committee and must be approved by the Board of Directors, which must include the Audit Committee. In voting at such meetings, directors who have an interest shall not be entitled to vote in order to be used in the decision-making of the Board of Directors or shareholders, as the case may be.

The Board of Directors shall ensure that the Company complies with the Securities and Exchange Act, rules, announcements, orders, or regulations of the Stock Exchange of Thailand, the Office of the Securities and Exchange Commission, the Securities and Exchange Commission, or the Capital Market Supervisory Board, including compliance with the requirements for disclosure of connected transactions and the acquisition or disposal of major assets of the Company. In addition, the Company will disclose such related party transactions in the notes to the financial statements audited by the Company's auditors, Form 56-1 one report, and the annual report or other information as required by the Stock Exchange of Thailand and relevant agencies.

Future Trends in Related Party Transactions

For any intercompany transactions that may occur in the future, the Company will comply with the Securities and Exchange Act and the rules, announcements, orders, or regulations of the Stock Exchange of Thailand. Persons who may have a conflict of interest or benefit from the intercompany transaction will not be entitled to vote on such transactions. Such intercompany transactions must be considered in accordance with the intercompany transaction policy to ensure that they are in the ordinary course of business and at a market price that can be compared or referenced to the price conditions that the Company has with external parties. In addition, entering into intercompany transactions must be considered for necessity and price appropriateness by the Audit Committee. However, if the Audit Committee does not have expertise in the intercompany transactions that may occur, the Company will consider having an independent appraiser, an independent specialist, or the Company's auditor provide an opinion on such intercompany transactions for the Audit Committee to consider and provide an opinion to the Board of Directors or shareholders, as the case may be. If the Company's ordinary shares are listed on the Stock Exchange of Thailand, the Company will disclose such intercompany transactions in the Annual Information Form (Form 56-1 One Report) in accordance with the criteria and the Securities and Exchange Act and the rules, announcements, orders, or regulations of the Stock Exchange of Thailand.


The Company expects that in the future, ordinary business transactions or transactions supporting the business of the Company and its subsidiaries, such as expenses for photocopying services and the SAP system, water analysis services, the purchase of water system equipment, the sale of water systems, medical service fees, office and warehouse space rental, etc., will continue to occur in the future, whereby the Company will ensure that the price and payment terms are in accordance with normal trade conditions.

Contents